The U.S. Food and Drug Administration (FDA) put the emergency use authorization for blood plasma as a COVID-19 Treatment on hold, reported The New York Times.
The normally obscure blood business is booming as various research and medical institutions are in a raced to develop tests, therapies and vaccines which many believe to be the key to successfully easing lockdowns and eradicating the threat of the coronavirus pandemic.